Switch to:

Denali Therapeutics Interest Expense

: $0.0 Mil (TTM As of Jun. 2019)
View and export this data going back to 2017. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Denali Therapeutics's interest expense for the three months ended in Jun. 2019 was $ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2019 was $0.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Denali Therapeutics's Operating Income for the three months ended in Jun. 2019 was $ -62.8 Mil. Denali Therapeutics's Interest Expense for the three months ended in Jun. 2019 was $ 0.0 Mil. GuruFocus does not calculate Denali Therapeutics's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Denali Therapeutics Interest Expense Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
Interest Expense -0.11 0.00 0.00 0.00

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Interest Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Denali Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2019 was 0 (Sep. 2018 ) + 0 (Dec. 2018 ) + 0 (Mar. 2019 ) + 0 (Jun. 2019 ) = $0.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics  (NAS:DNLI) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Denali Therapeutics's Interest Expense for the three months ended in Jun. 2019 was $0.0 Mil. Its Operating Income for the three months ended in Jun. 2019 was $-62.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2019 was $70.9 Mil.

Denali Therapeutics's Interest Coverage for the quarter that ended in Jun. 2019 is calculated as

GuruFocus does not calculate Denali Therapeutics's interest coverage with the available data.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies interest coverage is at least 5. Denali Therapeutics Inc has enough cash to cover all of its debt. Its financial situation is stable.


Denali Therapeutics Interest Expense Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK